Introduction {#S0001}
============

Headache and cardiovascular disease are highly prevalent, resulting in notable individual disability.^[@CIT0001],\ [@CIT0002]^ The association between migraine with aura (MA) and the risk of developing ischemic heart disease has been well established in previous studies.^[@CIT0003]^ Recent evidence have also confirmed the link between MA and retinopathy, small vessel arteriolar intima thickening, endothelial injury, and impaired endothelial vasoreactivity.^[@CIT0002]^ It seems that vascular comorbidities reported in migraineurs are limited to MA.^[@CIT0002]^

Due to the shared pathology of migraine and cardiovascular disease, several studies have investigated the prevalence of cardiovascular risk factors in migraine sufferers.^[@CIT0002]--[@CIT0005]^ These studies have reported contradictory results. Some have shown an elevation in the Framingham risk score in both patients with migraine without aura (MO) and MA, whereas others have reported the condition only in MA patients. Moreover, few attempts have been made to examine the independent effect of each factor by adjusting for other risk factors. According to our knowledge, no study has yet assessed the relationship between MO and cardiovascular risk factors in the Iranian population. In this cross-sectional study, we assessed the prevalence of cardiovascular risk factors in MO patients.

Materials and Methods {#S0002}
=====================

Study population {#S20003}
----------------

All Patients aged between 18 and 55 years referred to an outpatient neurology clinic between September 2009 and February 2010 were recruited. This study was approved by the Ethics Committee of Tehran University of Medical Sciences. From among these patients 614 accepted to participate in the study and signed an informed consent according to the Helsinki treaty.

Headache diagnoses {#S20004}
------------------

The diagnosis of headache was made by a neurologist expert in headache disorders in accordance with the International Headache Society (IHS) criteria for migraine without aura.^[@CIT0005]^ These criteria were: (1) those experiencing headache attacks lasting for 4--72 h (\< 4 h was accepted for those who reported visual disturbance before headache); or (2) those reporting headache with at least one of the following characteristics: pulsating quality, unilateral location or aggravation by physical activity; or (3) those experiencing at least one of the following symptoms during headache: nausea, photophobia, or phonophobia. Those who reported aura according to the IHS criteria were considered as MA and were excluded from the study. The control group comprised of patients, who did not suffer from any type of headache, with neurological problems, such as psychiatric disorders, epilepsy, and multiple sclerosis. Patients with any neurological disorder with confirmed vascular pathology, such as stroke or AVM, and those with a first degree relation within the case group were excluded.

Since all the cases and controls were recruited from the same medical center, they were believed to be socioeconomically matched. The age variable was tolerably matched (± 5 years). Considering the executive difficulties, female/male ratio was statistically different between the two groups; in multivariate analysis, however, it was eliminated as a confounder.

Cardiovascular risk factors {#S20005}
---------------------------

Fasting blood sample was obtained to measure fasting blood sugar (FBS), total cholesterol, Low density lipoprotein (LDL), and high density lipoprotein (HDL). Hyperglycemia was defined as having FBS ≥ 126 mg/dL, or consuming oral hypoglycemic agents or insulin. The patient was diagnosed with dyslipidemia if he/she had serum levels of total cholesterol ≥ 240 mg/dL, LDL ≥ 160 mg/dL, HDL ≤ 40 mg/dL, or was taking lipid lowering drugs.

Blood pressure was measured on the upper arm with the participant in a sitting position after a 10-minute rest, using a Mercury Ricter ™ sphygmomanometer. If systolic (SBP) or diastolic blood pressure (DBP) were higher than 140 or 90 mmHg, respectively, the measurement was repeated after 30 minutes. Hypertension (HTN) was defined as having SBP ≥ 140 mmHg or DBP ≥ 90 mmHg at the time of examination, or personal history of consuming antihypertensive drugs.

Anthropometric measurements were made by weight and height conventional scales. Weight was measured using a digital scale (Omron, Omron Healthcare, USA) to the nearest 0.1 kg. Height was measured to the nearest 0.1 cm, using a tape meter. Obesity was described as having body mass index (BMI) (calculated by dividing weight in kilograms by height in square meters) ≥ 30 kg/m^2^.

A questionnaire including information on the patient\'s past medical history of cerebrovascular disease (CVD) and ischemic stroke, HTN, diabetes mellitus (DM), dyslipidemia and consumption of antihypertensive drugs, oral hypoglycemic agents, insulin and lipid lowering drugs was completed for all the participants. The history of cigarette smoking and family history of early CVD were also questioned. The history of cigarette smoking was considered positive if the individual had used even one cigarette during the last month.^[@CIT0007]^ CVD history was considered positive if the participant reported a positive history of MI, coronary artery bypass graft surgery, or balloon or stent angioplasty.^[@CIT0007]^ Participants were also asked about CVD history in their first-degree relatives before the age of 55 in males, or 65 in females.^[@CIT0007]^

Statistical analysis {#S20006}
--------------------

For descriptive analysis of quantitative data, the Mean and Standard deviation were used. For qualitative data, frequency percentage was reported. To evaluate the association between Mo and risk factors, OR with 95% CI was used, and finally, to determine the real association of different variables, OR was adjusted by logistic regression model. We used multivariable logistic regression analysis to reduce the effect of confounding factors. The Statistical Package for Social Sciences (SPSS 15.0, SPSS Production Facility, Chicago, Illinois, USA) was used to analyze the data.

Results {#S0007}
=======

614 individuals were recruited. Male to female ratio was significantly lower in the case group (P = 0.02). Compared with the control group, migraineurs had higher age (P = 0.02), higher DBP (P = 0.01), lower FBS (P ≤ 0.001), higher total cholesterol (P = 0.006) and LDL (P = 0.006), and higher BMI (P = 0.02) ([Table 1](#T0001){ref-type="table"}).

###### 

Demographic characteristics of the studied population

  Variables                   Cases (n = 347)   Controls (n = 267)   P
  ------------------- ------- ----------------- -------------------- ---------
  Sex                 Male    15.8%             23.2%                0.02
  Female              84.1%   76.7%                                  
  Age(years)                  36.1              34.2                 0.02
  SBP                         120.3 ± 16.74     118 ± 18.52          0.12
  DBP                         78.3 ± 10.14      75.8 ± 11.38         0.01
  FBS                         95.7 ± 15.89      90.2 ± 16.95         ≥ 0.001
  Total Cholesterol           193.8 ± 35.95     182 ± 40.41          0.006
  LDL                         112.5 ± 33.27     107.7 ± 35.17        0.11
  HDL                         48.7 ± 10.58      47.2 ± 10.94         0.13
  BMI                         26.4 ± 5.12       25.5 ± 4.78          0.02

All continuous data is presented as mean ± SD (standard deviation)

HTN, hyperglycemia, dyslipidemia, obesity, and age were the probable confounders in the multivariate logistic regression analysis. The final model indicated HTN as the only variable related to MO (OR~adj~ = 1.9; P = 0.029). The odds ratio of the cardiovascular risk factors in the two studied groups is summarized in [table 2](#T0002){ref-type="table"}.

###### 

The crude odds ratio of the cardiovascular risk factors in the two groups

  Risk factors                 Cases           Controls       OR ~crude~ (95% CI)   P
  ---------------------------- --------------- -------------- --------------------- ----------
  Ischemic stroke history      4/281 (1%)      0/245 (0%)     \-                    0.074
  CVD history                  1/283 (0.3%)    0/245 (0%)     \-                    0.525
  Early familial CVD history   17/277 (6%)     12/252 (4%)    1.3 (0.6-2.7)         0.309
  HTN                          88/265 (33%)    38/245 (15%)   2.7 (1.7-4.16)        \< 0.001
  Hyperglycemia                17/208 (8%)     7/148 (4%)     1.8 (0.7-4.4)         0.144
  Dyslipidemia                 107/207 (51%)   93/164 (56%)   0.8 (0.5-1.2)         0.196
  Obesity                      59/275 (21%)    39/250 (15%)   1.4 (0.9-2.3)         0.054
  Cigarette smoking            14/279 (5%)     22/254 (8%)    0.5 (0.2-1.1)         0.067

Discussion {#S0008}
==========

In line with previous observations, our study showed MO to be associated with a higher prevalence of cardiovascular risk factors in the Iranian population. After adjusting for other risk factors, only HTN was significantly more prevalent among MO sufferers.

One of the possible underlying mechanisms linking headache to HTN is the renin-angiotensin system. It should be mention that DD gene, elevated ACE activity, and higher rate of MO attacks were reported in those with angiotensin converting enzyme (ACE).^[@CIT0006]^ Moreover, ACE inhibitors, such as captopril, and angiotensin II receptor blockers, such as lisinopril, have approved prophylactic effects in the treatment of migraine.^[@CIT0007]^ Yetkin et al. also found lower brachial artery flow in patients with transformed headache.^[@CIT0008]^ Another cross-sectional study reported a significant positive association between migraine and higher augmentation index (AI), a parameter of arterial stiffness.^[@CIT0007]^ Similarly, Bigal et al. found a significant relationship between hypertension and MO.^[@CIT0003]^ Ikeda et al., however, failed to report such an association.^[@CIT0009]^

The results regarding the relationship between high blood glucose levels and headache were highly controversial. Some studies have found higher blood glucose levels in patients with headache, whereas others have reported diabetes to be less prevalent in headache sufferers.^[@CIT0002],\ [@CIT0010]^ Our study showed higher FBS levels in the MO group; however, after adjusting for other CVD risks, the difference was not significant. Possible explanations for this observation are that, on the one hand, insulin resistance may be involved in the pathogenesis of migraine, and on the other hand, individuals with high blood glucose levels are prone to diabetic neuropathy that could interfere with peripheral neurogenic mechanism necessary for triggering migraine.^[@CIT0010],\ [@CIT0011]^

According to previous studies, obesity, hyperlipidemia, and smoking can increase an individual\'s risk of experiencing headache.^[@CIT0002],\ [@CIT0012]^ Winsvold et al. showed BMI, serum total cholesterol levels, and smoking to have a significant direct relationship with MO.^[@CIT0002]^ In the current study, only before adjusting for other CVD risk factors, the mean values of BMI and total cholesterol were higher in MO suffers. A possible explanation for the observed difference is the baseline differences noted in some of the CVD risk factors.

Considering the cross-sectional nature of the study, we cannot draw a conclusion as to a causal relationship between CVD risks and headache. Further prospective studies on larger populations are warranted.

Conclusion {#S0009}
==========

In conclusion, our study revealed that the prevalence of hypertension was higher in migraineurs without aura in comparison with non-migraineurs. Therefore, physicians must be more vigilant in examining these patients and prescribing medications that do not provoke hypertension.

The authors would like to thank Dr. Karbalaii and Dr. Ostovar for their sincere cooperation. We also thank the Research Development Center of Sina Hospital for their support.

Conflict of Interests {#S0010}
=====================

The authors declare no conflict of interest in this study.

Funding Acknowledgment {#S20011}
======================

This study was Dr. Samaneh Aalami Harandi\'s postgraduate thesis. It was supported by a grant from Tehran University of Medical Sciences to the study advisor, Prof. Mansoureh Togha \[grant number 89-03-54-11031\].
